相关实验视频
Updated: Jun 11, 2025

08:20
A Hyperandrogenic Mouse Model to Study Polycystic Ovary Syndrome
Published on: October 2, 2018
11.2K
在脏疾病中受损的11β-Hydroxysteroid脱酶2型活性 破坏了11-氧化生物合成
Maria Tomkins1,2, Tara McDonnell1,2, Leanne Cussen1,2
1Androgens in Health and Disease Research Group, Academic Division of Endocrinology, Department of Medicine, Royal College of Surgeons in Ireland, Dublin, D09 V2N0, Ireland.
The Journal of clinical endocrinology and metabolism
|October 9, 2024
概括
慢性病损害了11-oxygenated androgen生物合成,这是由于中的11β-hydroxysteroid脱酶2型 (HSD11B2) 酶的活性降低. 这项研究证实了HSD11B2的存在.
科学领域:
- 内分泌学 在内分泌学.
- 腎臟病學 (nephrology) 是一種醫學專業.
- 生物化学 生化学
背景情况:
- 11-氧化雄激素是上腺类固醇,需要外周激活.
- 11β-基固醇脱酶2型 (HSD11B2) 参与将11β-基二二转化为11-基二二 (11KA4).
- 脏是HSD11B2的主要部位,这表明脏功能与雄激素生物合成之间存在联系.
研究的目的:
- 调查HSD11B2在慢性病 (CKD) 中11氧化生成中的作用.
- 用临床,细胞和计算方法评估CKD患者的HSD11B2活性.
主要方法:
- 一项横截面研究比较了CKD患者 (n=85) 与健康对照 (n=46).
- 血清和尿路类固醇度使用液体染色学-并联质谱法进行测量.
- 一个计算模型根据酶动力学和患者数据估计了相对HSD11B2表达.
主要成果:
- HSD11B2活性与估计的淋巴细胞过率 (eGFR) 反向相关,由改变的皮质醇/皮质素比率表明.
- 慢性病患者表现出关键的11-氧化雄激素的血清水平较低,包括11-基托androstenedione (11KA4) 和11-基托 (11KT).
- 计算建模证实HSD11B2是CKD中受到影响的关键酶,预测表达与eGFR相关.
结论:
- 这项研究提供了第一个关于脏HSD11B2在11-oxygenated androgen生物合成中的关键作用的体内证据.
- 在CKD中HSD11B2活性受损有助于降低11-氧化水平.
- 需要进一步的研究,以了解这些发现在CKD患者中的临床意义.
相关概念视频
Adrenal Gland Disorders
1.4K
Adrenal gland disorders manifest when the production of adrenal hormones deviates from the norm, resulting in either excessive or insufficient concentrations.
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
1.4K
Antihypertensive Drugs: Direct Renin Inhibitors
505
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
505
Bone Disorders
3.4K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
3.4K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
394
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
394
Chronic Kidney Disease II: Clinical Manifestations
2
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
2
Antihypertensive Drugs: Potassium-Sparing Diuretics
469
Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
469

